Comparative efficacy and safety of six non-ergot dopamine-receptor agonists in early Parkinson's disease: a systematic review and network meta-analysis

Comparative efficacy and safety of six non-ergot dopamine-receptor agonists in early Parkinson's disease: a systematic review and network meta-analysis

BackgroundNon-ergot dopamine agonists (NEDAs) have been used as monotherapy or as an adjunctive therapy to levodopa for many years. Novel long-acting formulations of NEDAs including pramipexole extended-release (ER), ropinirole prolonged-release (PR), and rotigotine transdermal patch have been devel...

Full description

Bibliographic Details
Main Authors: Xiang-Ting Chen, Qian Zhang, Fei-Fei Chen, Si-Yuan Wen, Chang-Qing Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Neurology
Subjects:
Parkinson's disease
network meta-analysis
dopamine-receptor agonists
ropinirole
piribedil
rotigotine
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2023.1183823/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2023.1183823/full

Similar Items